Return to search

Ysios Capital Raising First Fund

Ysios Capital Partners of Barcelona, Spain is raising Euro 65 million for its debut fund, which will focus on venture capital opportunities in the biotech space. The firm will support early-stage companies, later-stage companies and pharmaceutical spinouts. Its team includes: managing partner Joel Jean Mairet, co-founder and CEO of Glycart Biotechnology AG; partner Christina Garmendia, co-founder and president of the Genetrix Group; and partner Julia Salaverria, former director of funds for Talde.